Lissette M. Saavedra

Lissette M. Saavedra

Auto-generated profile, based on publicly available information

Lissette M. Saavedra

RTI International

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Psychological Bulletin
Verified
Journal Article
Closed access
DHDenise Hien
Denise Hien
SPSantiago Papini
Santiago Papini
LSLissette M. Saavedra
Lissette M. Saavedra
Alexandria G. BauerAlexandria G. Bauer
Alexandria G. Bauer
LRLesia M. Ruglass
Lesia M. Ruglass
AMAntonio A. Morgan-López
Antonio A. Morgan-López
We conducted a systematic review and network meta-analyses (NMA) of psychotherapy and pharmacologic treatments for individuals with co-occurring posttraumatic stress disorder (PTSD) and alcohol or other drug use disorder (AOD). A comprehensive search spanning 1995-2019 yielded a pool of 39 studies for systematic review, including 24 randomized controlled trials for the NMA. Study interventions were grouped by target of treatment (PTSD + AOD, PTSD-only, and AOD-only) and approach (psychotherapy or medication). Standardized mean differences (SMD) from the NMA yielded evidence that at the end of treatment, integrated, trauma-focused therapy for PTSD + AOD was more effective at reducing PTSD symptoms than integrated, non-trauma-focused therapy (SMD = -0.30), AOD-focused psychotherapy (SMD = -0.29), and other control psychotherapies (SMD = -0.43). End-of-treatment alcohol use severity was less for AOD medication compared to placebo medication (SMD = -0.36) and trauma-focused therapy for PTSD + placebo medication (SMD = -0.67), and less for trauma-focused psychotherapy + AOD medication compared to PTSD medication (SMD = -0.53), placebo medication (SMD = -0.50), and trauma-focused psychotherapy + placebo medication (SMD = -0.81). Key limitations include the small number of studies in the NMA for pharmacologic treatments and the lack of demographic diversity apparent in the existing literature. Findings suggest room for new studies that can address limitations in study sample composition, sample sizes, retention, and apply new techniques for conducting comparative effectiveness in PTSD + AOD treatment. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

1 February 2012 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
DHDenise Hien
Denise Hien
AMAntonio A. Morgan-Lopez
Antonio A. Morgan-Lopez
ACAimee N. C. Campbell
Aimee N. C. Campbell
LSLissette M. Saavedra
Lissette M. Saavedra
EWElwin Wu
Elwin Wu
ENEdward V. Nunes
Edward V. Nunes
This study uses data from the largest effectiveness trial to date on treatment of co-occurring posttraumatic stress and substance use disorders, using advances in statistical methodology for modeling treatment attendance and membership turnover in rolling groups. Women receiving outpatient substance abuse treatment (N = 353) were randomized to 12 sessions of Seeking Safety or a health education control condition. Assessments were completed at baseline and at 1 week, 3, 6, and 12 months posttreatment. Outcome measures were alcohol and cocaine use in the prior 30 days captured using the Addiction Severity Index. Latent class pattern mixture modeling (LCPMM) was used to estimate attendance patterns and to test for treatment effects within and across latent attendance patterns and group membership turnover. Across LCPMM analyses for alcohol and cocaine use, similar treatment attendance patterns emerged: Completers never decreased below an 80% probability of attendance, droppers never exceeded a 41% probability of attendance, and titrators demonstrated a 50% to 80% probability of attendance. Among completers, there were significant decreases in alcohol use from baseline to 1-week posttreatment, followed by nonsignificant increases in alcohol during follow-up. No differences between treatment conditions were detected. Titrators in Seeking Safety had lower rates of alcohol use from 1-week through 12-month follow-up compared with control participants. Droppers had nonsignificant increases in alcohol during both study phases. Cocaine use findings were similar but did not reach significance levels. The impact of client self-modulation of treatment dosage and group membership composition may influence behavioral treatment outcomes among this population.

1 August 2021 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
LSLissette M. Saavedra
Lissette M. Saavedra
AMAntonio A. Morgan-López
Antonio A. Morgan-López
DHDenise A. Hien
Denise A. Hien
TLTeresa López-Castro
Teresa López-Castro
LRLesia M. Ruglass
Lesia M. Ruglass
JHJessica Hamblen
Jessica Hamblen

22 December 2021 in European Journal of Psychotraumatology
Verified
Journal Article
Open access
DHDenise Hien
Denise Hien
SFSkye Fitzpatrick
Skye Fitzpatrick
LSLissette M. Saavedra
Lissette M. Saavedra
CEChantel T. Ebrahimi
Chantel T. Ebrahimi
SNSonya B. Norman
Sonya B. Norman
AMAntonio A. Morgan-López
Antonio A. Morgan-López
The present study leveraged the expertise of an international group of posttraumatic stress and substance use disorder (PTSD+SUD) intervention researchers to identify which methods of categorizing ... Experts in PTSD+SUD clinical trials were surveyed to identify principles for treatment classification of PTSD+SUD behavioural therapies.Results indicated some consensus around ‘trauma-focused’ vs ‘... Antecedentes/Objetivo: El presente estudio aprovechó la experticia de un grupo internacional de investigadores de intervención en trastorno de estrés postraumático y trastorno por uso de sustancias... 背景/目的: 本研究利用了一个国际创伤后应激障碍和物质使用障碍 (PTSD+SUD) 干预研究人员的专业知识, 以确定对于PTSD+SUD并发患者 针对 SUD, PTSD 或 PTSD+SUD 的干预措施分类方法可能是推进未来系统综述, 元分析和旨在比较各种心理治疗类型效果的比较有效性研究的最佳选择。方法: 使用两步过程来评估分类术语。首先, 我们从 PTSD+SUD 临床试验, 系统和文...

11 November 2020 in Journal of Traumatic Stress
Verified
Journal Article
Closed access
PDF file
LSLissette M. Saavedra
Lissette M. Saavedra
AMAntonio A. Morgan‐López
Antonio A. Morgan‐López
DHDenise Hien
Denise Hien
TKTherese K. Killeen
Therese K. Killeen
SBSudie E. Back
Sudie E. Back
TLTeresa Lopez-Castro
Teresa Lopez-Castro

15 February 2023 in International Journal of Methods in Psychiatric Research
Verified
Journal Article
Open access
AMAntonio A. Morgan‐López
Antonio A. Morgan‐López
LSLissette M. Saavedra
Lissette M. Saavedra
DHDenise Hien
Denise Hien
SNSonya B. Norman
Sonya B. Norman
SFSkye S. Fitzpatrick
Skye S. Fitzpatrick
SBSudie E. Back
Sudie E. Back
Objective: Symptom counts as the basis for Post‐Traumatic Stress Disorder (PTSD) diagnoses in the DSM presume each symptom is equally reflective of underlying disorder severity. However, the “equal weight” assumption fails to fit PTSD symptom data when tested. The present study developed an enhanced PTSD diagnosis based on (a) a conventional PTSD diagnosis from a clinical interview and (b) an empirical classification of full PTSD that reflected the relative clinical weights of each symptom.Method: Baseline structured interview data from Project Harmony (N = 2658) was used. An enhanced diagnosis for full PTSD was estimated using an empirical threshold from moderated nonlinear factor analysis (MNLFA) latent PTSD scale scores, in combination with a full conventional PTSD diagnosis based on interview data.Results: One in 4 patients in the sample had a PTSD diagnosis that was inconsistent with their empirical PTSD grouping, such that the enhanced diagnostic standard reduced the diagnostic discrepancy rate by 20%. Veterans, and in particular female Veterans, were at greatest odds for discrepancy between their underlying PTSD severity and DSM diagnosis.Conclusion: Psychometric methodologies that differentially weight symptoms can complement DSM criteria and may serve as a platform for symptom prioritization for diagnoses in future editions of DSM.